Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Sautel

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
International Clinical Psychopharmacology|September 1, 1995
The D3 receptor and its relevance in psychiatryJ C Schwartz, N Griffon, J Diaz, et al.
Molecular Psychiatry|August 14, 1998
Dopamine D3 receptor gene variants and substance abuse in schizophreniaM O Krebs, F Sautel, M C Bourdel, et al.
Nature|August 4, 1999
Selective inhibition of cocaine-seeking behaviour by a partial dopamine D3 receptor agonistM Pilla, S Perachon, F Sautel, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|January 1, 1995
The dopamine D3 receptor and schizophrenia: pharmacological, anatomical and genetic approachesN Griffon, P Sokoloff, J Diaz, et al.
Plos Pathogens|June 5, 2010
A complex small RNA repertoire is generated by a plant/fungal-like machinery and effected by a metazoan-like Argonaute in the single-cell human parasite Toxoplasma gondiiLaurence Braun, Dominique Cannella, Philippe Ortet, et al.
Molecular Psychiatry|August 14, 1998
Homozygosity at the dopamine D3 receptor gene is associated with opiate dependenceE Duaux, P Gorwood, N Griffon, et al.
Biochemical Society Transactions|February 1, 1996
Functional models for the dopamine D3 receptorN Griffon, F Sautel, C Pilon, et al.
Cancer Research|December 2, 2010
Antitumor activity of pyridocarbazole and benzopyridoindole derivatives that inhibit protein kinase CK2Renaud Prudent, Virginie Moucadel, Chi-Hung Nguyen, et al.
Scientific Reports|November 6, 2019
Discovery of holoenzyme-disrupting chemicals as substrate-selective CK2 inhibitorsIrina Kufareva, Benoit Bestgen, Paul Brear, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|April 20, 2010
New potent dual inhibitors of CK2 and Pim kinases: discovery and structural insightsMiriam López-Ramos, Renaud Prudent, Virginie Moucadel, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
International Clinical Psychopharmacology|September 1, 1995
The D3 receptor and its relevance in psychiatryJ C Schwartz, N Griffon, J Diaz, et al.
Molecular Psychiatry|August 14, 1998
Dopamine D3 receptor gene variants and substance abuse in schizophreniaM O Krebs, F Sautel, M C Bourdel, et al.
Nature|August 4, 1999
Selective inhibition of cocaine-seeking behaviour by a partial dopamine D3 receptor agonistM Pilla, S Perachon, F Sautel, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|January 1, 1995
The dopamine D3 receptor and schizophrenia: pharmacological, anatomical and genetic approachesN Griffon, P Sokoloff, J Diaz, et al.
Plos Pathogens|June 5, 2010
A complex small RNA repertoire is generated by a plant/fungal-like machinery and effected by a metazoan-like Argonaute in the single-cell human parasite Toxoplasma gondiiLaurence Braun, Dominique Cannella, Philippe Ortet, et al.
Molecular Psychiatry|August 14, 1998
Homozygosity at the dopamine D3 receptor gene is associated with opiate dependenceE Duaux, P Gorwood, N Griffon, et al.
Biochemical Society Transactions|February 1, 1996
Functional models for the dopamine D3 receptorN Griffon, F Sautel, C Pilon, et al.
Cancer Research|December 2, 2010
Antitumor activity of pyridocarbazole and benzopyridoindole derivatives that inhibit protein kinase CK2Renaud Prudent, Virginie Moucadel, Chi-Hung Nguyen, et al.
Scientific Reports|November 6, 2019
Discovery of holoenzyme-disrupting chemicals as substrate-selective CK2 inhibitorsIrina Kufareva, Benoit Bestgen, Paul Brear, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|April 20, 2010
New potent dual inhibitors of CK2 and Pim kinases: discovery and structural insightsMiriam López-Ramos, Renaud Prudent, Virginie Moucadel, et al.
Pageof 2